Furthermore, programmed death-ligand 1 (PD-L1) expression, tumor mutational burden (TMB), and immune cell infiltration are immunological biomarkers associated with responses to ICI in NSCLC (49). The gene discussed is CD274; the disease is non-small cell lung carcinoma.